Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CHRNA2 Gene Epilepsy, nocturnal frontal lobe type 4 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Comprehensive Epilepsy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 318 |
|
CHRNA2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 1 | 166 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genomic Unity Epilepsy Analysis (includes STR analysis of 6 loci) Variantyx, Inc. United States | 1 | 378 |
|
Amplexa Genetics Amplexa Genetics A/S Denmark | 1 | 125 |
|
Epilepsy - Intellectual Disability - Autism Spectrum Disorder Amplexa Genetics Amplexa Genetics A/S Denmark | 1 | 600 |
|
Epilepsy: Autosomal Dominant Nocturnal Frontal Lobe Epilepsy, Type 4 via the CHRNA2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Invitae United States | 466 | 297 |
|
CGC Genetics Unilabs Portugal | 1 | 832 |
|
Nocturnal frontal lobe epilepsy (WES based NGS panel of 8 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 8 |
|
Nocturnal frontal lobe epilepsy (sequence analysis of CHRNA2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Nocturnal frontal lobe epilepsy type 4 (deletion/duplication analysis of CHRNA2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Mendelics Brazil | 1 | 240 |
|
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 139 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 696 |
|
MUSCULAR DISORDERS- EMCG GLOBAL EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 416 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.